This page shows the latest Alpharma news and features for those working in and with pharma, biotech and healthcare.
The four generics companies - Generics UK, Arrow, Alpharma and Ranbaxy - were fined around 52m, and those judgments have also been upheld by the General Court of the EU.
Former Merck subsidiary Generics (UK) Ltd and Alpharma (acquired by Actavis in 2005) had been sued by GSK for patent infringement but the cases were dropped after the agreements to defer ... Now, Merck has been fined £5.8m with regard to the involvement
In total the EC hit eight companies, among them Alpharma (now part of Zoetis), Merck KGaA and Ranbaxy, with penalties worth a total of 146m, but Lundbeck with its 93.8m
Lundbeck, Alpharma, Merck KGaA, Generics UK, Arrow and Ranbaxy all hit. ... Celexa (citalopram) brand owner Lundbeck was subjected to the majority of the fine (almost 94m) with the remainder shared between several companies including Alpharma (now part
Lundbeck, Merck KGaA, Generics UK, Arrow, Resolution Chemicals, Xellia Pharmaceuticals, Alpharma and Ranbaxy are all in line for financial penalties from the European Commission (EC), according to Reuters.
market. The OFT, which is the government department responsible for protecting consumers, said GSK infringed competition law by making “substantial payments” to Alpharma, Generics (UK) and Norton Healthcare to delay plans ... These payments were part
More from news
Approximately 2 fully matching, plus 10 partially matching documents found.
Xellia is a spin out from Alpharma and had sales of $220m in 2012.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
He began his pharmaceutical industry career at Organon, working in drug safety and medical knowledge management, before joining Alpharma as director of drug safety. ... He was promoted to senior director of medical affairs and then after King
Nasrat Hakim also has senior experience at Watson and Alpharma. Nasrat Hakim has left his international VP position at Actavis to join Elite Pharmaceuticals as president and CEO. ... His positions prior to Actavis include global VP, quality and
Other previous positions include senior VP commercial operations at pain specialists Alpharma Pharmaceuticals, VP marketing at Endo Pharmaceuticals and VP global strategy and commercial development at Mallinckrodt.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...